“We are extremely fortunate to have experts in all areas of kidney cancer treatment at UF Health,” said Li-Ming Su, MD, chair of the department of urology.

“The new treatment would combine this antibody with a very potent form of chemotherapy,” said Paul Crispen, MD, an associate professor in the UF Department of Urology. “This antibody drug conjugate could potentially deliver the chemotherapy selectively to areas of cancer to increase efficacy and limit toxicity.”

Core Lecture with Dr. Paul Crispen: "CIS of the Bladder" | Tuesday, 9/28/21 at 7:00 am

The official podcast of UF Health provides engaging insight on today’s trending health care topics. Earn CME credits while learning about clinical issues and research advances from experts at UF Health Shands Hospital, one of the nation’s top academic health centers. Subscribe to UF Health MedEd Cast and join the conversation!

Bladder cancer is the second most common urologic cancer in adults. There are 67,000 new cases of bladder cancer each year in the United States.

Southeastern Section of the AUA Virtual 85th Annual Meeting April 23 - 24, 2021 #SESAUA2021

From left to right, Dr. Li-Ming Su, Dr. Brian Ramnaraign, Dr. Paul Crispen & Dr. Padraic O’Malley The fountains of Hotel Eleo at the University of Florida were lit orange to honor all who have been touched by Kidney Cancer. Representing the Multidisciplinary Urologic Oncology Clinic team are: Dr. Li-Ming…

UF Health Cancer Center Oncology Grand Rounds | February 10, 2021 | 12:00 PM

As prostate cancer is the most common genitourinary cancer treated by a urologist and by far the most visible cancer from the standpoint of public awareness, our UF Health Urology team members are doing their part to increase awareness of this challenging disease by wearing a light blue ribbon lapel pin throughout the duration of the month of September.

We are pleased to announce the appointment of Dr. Paul Crispen to the Pete and Carolyn Newsome Professorship in Urologic Oncology.